|
Olympus reviewed a literature titled "long- vs short-segment barrett's esophagus-derived adenocarcinoma: clinical features and outcomes of endoscopic submucosal dissection".Background the incidence of barrett¿s esophageal adenocarcinoma (bea) is increasing, and endoscopic submucosal dissection (esd) has been frequently performed for its treatment.However, the differences between the characteristics and esd outcomes between short- and long-segment bea (ssbea and lsbea, respectively) are unclear.We compared the clinicopathological characteristics and short- and long-term outcomes of esd between both groups.Methods we retrospectively reviewed 155 superficial beas (106 ssbeas and 49 lsbeas) treated with esd in 139 patients and examined their clinicopathological features and esd outcomes.Ssbea and lsbea were classified based on whether the maximum length of the background mucosa of bea was < 3 cm or = 3 cm, respectively.Results compared with ssbea, lsbea showed significantly higher proportions of cases with the macroscopically flat type (36.7% vs.5.7%, p < 0.001), left wall location (38.8% vs.11.3%, p < 0.001), over half of the tumor circumference (20.4% vs.1.9%, p < 0.001), and synchronous lesions (17.6% vs.0%, p < 0.001).Compared with ssbea, regarding esd outcomes, lsbea showed significantly longer resection duration (91.0 min vs.60.5 min, p < 0.001); a lower proportion of submucosal invasion (14.3% vs.29.2%, p = 0.047), horizontal margin negativity (79.6% vs.94.3%, p = 0.0089), and r0 resection (69.4% vs.86.8%, p = 0.024); and a higher proportion of post-procedural stenosis cases (10.9% vs.1.9%, p = 0.027).The 5-year cumulative incidence of metachronous cancer in patients without additional treatment was significantly higher for lsbea than for ssbea (25.0% vs.0%, p < 0.001).Type of adverse events/number of patients stricture (7) stricture was defined as the narrowing of the esophageal lumen to the point that a 9.8-mm-thick endoscope could not pass through after esd.When strictures occurred, endoscopic balloon dilation was performed until enabling endoscope passage.Conclusions the clinicopathological features of lsbea and ssbea and their treatment outcomes differed in many aspects.As lsbeas are difficult to diagnose and treat and show a high risk of metachronous cancer development, careful esd and follow-up or eradication of the remaining be may be required.The event date was reported as the publication date of the literature.
|
|
This report is being supplemented to provide additional information, based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device, since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the reported event was likely, an accident or a complication associated with a surgical procedure, while using the subject device.However, there was no complaint reported on the subject device.And no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes, additional information received from the author.B5 updated accordingly.Olympus will continue to monitor field performance for this device.
|
|
It was reported, that there was no device malfunction, during any of the procedures described in the article.Also, an olympus device did not cause or contribute to the reported adverse events.
|